Literature DB >> 11250951

Prevention of contrast nephropathy after cardiac catheterisation.

C S Baker, L R Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11250951      PMCID： PMC1729687          DOI： 10.1136/heart.85.4.361

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  Are we still wondering or wandering in the dark?

Authors:  Davide Cattano
Journal:  Intern Emerg Med       Date:  2011-03-17       Impact factor: 3.397

Review 2.  Comparative tolerability of contrast media used for coronary interventions.

Authors:  Enrique Esplugas; Angel Cequier; Joan A Gomez-Hospital; Bruno García Del Blanco; Francisco Jara
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Contrast-induced acute kidney injury: short- and long-term implications.

Authors:  Steven D Weisbord; Paul M Palevsky
Journal:  Semin Nephrol       Date:  2011-05       Impact factor: 5.299

4.  N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial.

Authors:  Ricardo M Heguilén; Amador A Liste; Miguel Payaslian; Martin Gabriel Ortemberg; Lautaro Martin Albarracín; Amelia Rita Bernasconi
Journal:  Clin Exp Nephrol       Date:  2012-11-10       Impact factor: 2.801

Review 5.  N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.

Authors:  Raymond Liu; Deepu Nair; Joachim Ix; Dan H Moore; Stephen Bent
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

6.  Comparison of Access Site-Related Complications and Quality of Life in Patients after Invasive Cardiology Procedures According to the Use of Radial, Femoral, or Brachial Approach.

Authors:  Jan Roczniak; Wojciech Koziołek; Marcin Piechocki; Tomasz Tokarek; Andrzej Surdacki; Stanisław Bartuś; Michał Chyrchel
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.